Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2025-02-11 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recordings of an earnings call conducted on February 11, 2025, for the quarter and nine months ended December 31, 2024. It provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document is short (1141 characters) and serves as an announcement or notification about the earnings call recording availability. According to the rules, announcements about earnings calls or their recordings without the full transcript or financial data should be classified as Regulatory Filings (RNS), as it does not contain the actual earnings release or call transcript.
2025-02-11 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and NSE India) regarding the publication of newspaper advertisements about the financial results of the company for the quarter and nine months ended December 31, 2024. It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document does not contain the full financial report or detailed financial statements but rather encloses copies of newspaper advertisements summarizing the financial results. The document length is about 15,000 characters, but the content is primarily an announcement of the publication of financial results in newspapers, not the financial results report itself. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement related to financial results publication but does not contain the full report or detailed financial data itself.
2025-02-11 English
Integrated Filing- Financial
Interim / Quarterly Report Classification · 95% confidence The document is titled as an "Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024" and includes an Independent Auditor's Review Report on consolidated unaudited financial results for the quarter and year-to-date period ending December 31, 2024. It references compliance with SEBI regulations and Indian Accounting Standards (Ind AS 34) for interim financial reporting. The content includes detailed financial results for the quarter and nine months, auditor's review statements, and notes on the financials. The document length is substantial (15,000 characters), and it contains actual financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or certification but a full financial report for the interim period. 9M 2025
2025-02-10 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation Q3FY25 & 9MFY25' and is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a presentation for investors and analysts. It contains detailed financial highlights, business overview, management commentary, segment revenue, and operating metrics for the quarter and nine months ended December 31, 2024. The content is consistent with an investor presentation focusing on financials, strategy, and market position. It is not a full annual or interim report, audit report, earnings release, or regulatory filing. The document length is substantial (15,000 characters) and contains detailed presentation content rather than just an announcement or certification. Therefore, the appropriate classification is Investor Presentation (IP).
2025-02-10 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing the financial results for the third quarter and nine months ended December 31, 2024. It includes detailed financial data such as total income, EBITDA, PAT, and EPS for Q3FY25 and 9MFY25, along with year-over-year and quarter-over-quarter growth percentages. The document also mentions an upcoming earnings call to discuss these results. The presence of substantive financial data and analysis for a quarterly period indicates this is a quarterly earnings report rather than just a brief earnings release or announcement. The length of the document (5483 characters) and the detailed financial tables support classification as an Interim / Quarterly Report (IR). Q3 2025
2025-02-10 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of the unaudited financial results for the quarter and nine months ended December 31, 2024, including consolidated and standalone financial results. It includes an Independent Auditor's Review Report pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which specifically governs interim financial reporting. The document contains substantive financial data, analysis, and notes prepared under Indian Accounting Standards (Ind AS 34) for interim financial reporting. The presence of quarterly and nine-month financial results, auditor's review, and compliance with interim reporting standards clearly identifies this as an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains actual financial statements, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2025
2025-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.